$CWBHF
Stock $cwbhf

$cwbhf Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000175015523000021 Filed on March 23, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$17.01M	$18.87M	$74.14M
YoY Change	-12.12%	-24.01%	-22.85%
Cost Of Revenue	$7.093M	$29.44M	$54.73M
YoY Change	-7.2%	42.74%	15.2%
Gross Profit	$9.917M	-$10.57M	$19.41M
YoY Change	-15.33%	-351.28%	-60.05%
Gross Profit Margin	58.3%	-56.02%	26.18%
Selling, General & Admin	$17.51M	$21.41M	$70.06M
YoY Change	-13.96%	-12.16%	-28.25%
% of Gross Profit	176.6%		360.93%
Research & Development	$546.0K		$3.435M
YoY Change			-37.57%
% of Gross Profit	5.51%		17.7%
Depreciation & Amortization	$3.792M	$3.206M	$8.968M
YoY Change	82.48%	14.62%	-18.66%
% of Gross Profit	38.24%		46.2%
Operating Expenses	$17.51M	$21.41M	$70.06M
YoY Change	-13.96%	-12.16%	-32.07%
Operating Profit	-$7.596M	-$31.98M	-$52.49M
YoY Change	-12.1%	58.55%	-64.31%
Interest Expense	$5.382M	-$3.580M	-$7.480M
YoY Change	5282.0%	-1131.7%	-179.33%
% of Operating Profit
Other Income/Expense, Net	-$698.0K	$440.0K	$744.0K
YoY Change	730.95%	-263.57%	1358.82%
Pretax Income	-$2.912M	-$35.14M	-$59.22M
YoY Change	-66.24%	-70.25%	-56.95%
Income Tax	$0.00	$91.00K	$91.00K
% Of Pretax Income
Net Earnings	-$2.912M	-$35.23M	-$59.31M
YoY Change	-66.24%	-70.21%	-56.93%
Net Earnings / Revenue	-17.12%	-186.71%	-80.0%
Basic Earnings Per Share	-$0.02		-$0.40
Diluted Earnings Per Share	-$0.02	-$0.23	-$0.40
COMMON SHARES
Basic Shares Outstanding	152.4M shares	151.6M shares	146.6M shares
Diluted Shares Outstanding	152.3M shares		146.6M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$60.78M	$66.96M	$66.96M
YoY Change	319.27%	243.51%	243.51%
Cash & Equivalents	$60.78M	$66.96M	$66.96M
Short-Term Investments
Other Short-Term Assets	$7.944M	$7.998M	$7.998M
YoY Change	17.13%	-1.2%	-1.2%
Inventory	$25.57M	$26.95M	$26.95M
Prepaid Expenses		$2.612M
Receivables	$2.578M	$1.847M	$1.847M
Other Receivables	$4.261M	$573.0K	$0.00
Total Short-Term Assets	$101.1M	$103.8M	$103.8M
YoY Change	15.32%	8.3%	8.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.96M	$29.33M	$45.85M
YoY Change	-18.83%	-18.72%	-19.23%
Goodwill		$0.00
YoY Change
Intangibles	$1.559M	$1.771M
YoY Change	-40.13%	-37.71%
Long-Term Investments		$0.00
YoY Change
Other Assets	$1.532M	$5.770M	$9.390M
YoY Change	-22.39%	179.83%	-37.66%
Total Long-Term Assets	$74.83M	$83.88M	$83.88M
YoY Change	2.34%	10.8%	10.8%
TOTAL ASSETS
Total Short-Term Assets	$101.1M	$103.8M	$103.8M
Total Long-Term Assets	$74.83M	$83.88M	$83.88M
Total Assets	$176.0M	$187.6M	$187.6M
YoY Change	9.42%	9.4%	9.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.707M	$4.018M	$4.018M
YoY Change	-27.98%	-20.42%	-20.42%
Accrued Expenses	$8.406M	$6.899M	$9.205M
YoY Change	27.19%	-27.91%	-3.81%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$445.0K	$445.0K
YoY Change		-91.98%	-91.98%
Total Short-Term Liabilities	$22.62M	$21.43M	$21.43M
YoY Change	27.14%	6.23%	6.23%
LONG-TERM LIABILITIES
Long-Term Debt	$38.43M	$37.43M	$37.43M
YoY Change	93.43%	79.21%	79.21%
Other Long-Term Liabilities	$40.02M	$51.28M	$51.28M
YoY Change	333425.0%	427258.33%	427258.33%
Total Long-Term Liabilities	$78.45M	$88.71M	$88.71M
YoY Change	653641.67%	739150.0%	324.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.62M	$21.43M	$21.43M
Total Long-Term Liabilities	$78.45M	$88.71M	$88.71M
Total Liabilities	$101.1M	$110.1M	$110.1M
YoY Change	168.29%	168.19%	168.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$250.8M	-$247.9M
YoY Change	27.17%	31.45%
Common Stock	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$74.90M	$77.51M	$77.51M
YoY Change
Total Liabilities & Shareholders Equity	$176.0M	$187.6M	$187.6M
YoY Change	9.42%	9.4%	9.4%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.912M	-$35.23M	-$59.31M
YoY Change	-66.24%	-70.21%	-56.93%
Depreciation, Depletion And Amortization	$3.792M	$3.206M	$8.968M
YoY Change	82.48%	14.62%	-18.66%
Cash From Operating Activities	-$6.073M	-$2.716M	-$5.315M
YoY Change	29.79%	-56.44%	-82.02%
INVESTING ACTIVITIES
Capital Expenditures		-$146.0K	$265.0K
YoY Change		-82.41%	-105.39%
Acquisitions
YoY Change
Other Investing Activities	$40.00K	$306.0K	$0.00
YoY Change		133.59%	-100.0%
Cash From Investing Activities	-$40.00K	$452.0K	$395.0K
YoY Change	-85.24%	-164.66%	-103.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$69.00K	52.71M	$52.39M
YoY Change	46.81%	883.65%	551.69%
NET CHANGE
Cash From Operating Activities	-$6.073M	-2.716M	-$5.315M
Cash From Investing Activities	-$40.00K	452.0K	$395.0K
Cash From Financing Activities	-$69.00K	52.71M	$52.39M
Net Change In Cash	-$6.182M	50.45M	$47.47M
YoY Change	23.71%	-3303.17%	-242.51%
FREE CASH FLOW
Cash From Operating Activities	-$6.073M	-$2.716M	-$5.315M
Capital Expenditures		-$146.0K	$265.0K
Free Cash Flow		-$2.570M	-$5.580M
YoY Change		-52.45%	-77.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001750155
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://charlottesweb.com/20221231#BusinessCombinationPurchaseOptionAndOtherDerivativeAssets
CY2021	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	84300000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	152422498	shares
CY2022	dei	Auditor Firm AuditorFirmId	42
CY2022	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2022	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66963000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1847000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	26953000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7998000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	10764000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	95807000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36085000	usd
CY2021Q4	cweb	License And Media Rights LicenseAndMediaRights	0	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20679000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1771000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2843000	usd
CY2021Q4	cweb	Business Combination Purchase Option And Other Derivative Assets BusinessCombinationPurchaseOptionAndOtherDerivativeAssets	13000000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1037000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2062000	usd
CY2021Q4	us-gaap	Assets Assets	171513000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5049000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9570000	usd
CY2022Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	445000	usd
CY2021Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	3448000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2306000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2103000	usd
CY2022Q4	cweb	License Payable Current LicensePayableCurrent	7759000	usd
CY2021Q4	cweb	License Payable Current LicensePayableCurrent	0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21427000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20170000	usd
CY2022Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	6000	usd
CY2021Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	385000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17905000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20500000	usd
CY2021Q4	cweb	Derivative And Other Liabilities Noncurrent DerivativeAndOtherLiabilitiesNoncurrent	12000	usd
CY2022Q4	cweb	License Payable Noncurrent LicensePayableNoncurrent	20383000	usd
CY2021Q4	cweb	License Payable Noncurrent LicensePayableNoncurrent	0	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	37421000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Liabilities Liabilities	110137000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	41067000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	152135026	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	152135026	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	144659964	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	144659964	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	325431000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	319059000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-247927000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188614000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	77505000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	130446000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	187642000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	171513000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74139000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96092000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	54728000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	47507000	usd
CY2022	us-gaap	Gross Profit GrossProfit	19411000	usd
CY2021	us-gaap	Gross Profit GrossProfit	48585000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	70060000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	97641000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1837000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	98003000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-52486000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-147059000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	51000	usd
CY2022	cweb	Change In Fair Value Of Financial Instruments And Other Gain Loss ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss	-7480000	usd
CY2021	cweb	Change In Fair Value Of Financial Instruments And Other Gain Loss ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss	9429000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-59222000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-137579000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	91000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	143000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59313000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.98
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146631767	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146631767	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140769247	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	140769247	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	254242000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30000	usd
CY2021	cweb	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	441000	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	146000	usd
CY2021	cweb	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	1460000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4023000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-137722000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	130446000	usd
CY2022	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-190000	usd
CY2022	cweb	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	164000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3060000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-65000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	77505000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59313000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-137722000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8968000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11025000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1837000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	98003000	usd
CY2022	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	-7480000	usd
CY2021	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	9305000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1226000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1509000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	23394000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	9729000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3403000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5483000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2146000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2368000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	184000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-390000	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	958000	usd
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2946000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	948000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1730000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1023000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3781000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-694000	usd
CY2022	cweb	Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability	2012000	usd
CY2021	cweb	Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability	2230000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3577000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2911000	usd
CY2022	cweb	Increase Decrease In License Payable IncreaseDecreaseInLicensePayable	500000	usd
CY2021	cweb	Increase Decrease In License Payable IncreaseDecreaseInLicensePayable	0	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	10764000	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	676000	usd
CY2022	cweb	Increase Decrease In Cultivation Liabilities IncreaseDecreaseInCultivationLiabilities	-4000000	usd
CY2021	cweb	Increase Decrease In Cultivation Liabilities IncreaseDecreaseInCultivationLiabilities	-7166000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	4362000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	177000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5315000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29559000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	265000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4918000	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	660000	usd
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	13000	usd
CY2022	cweb	Payments To Acquire Notes Receivable Net Of Proceeds From Collection PaymentsToAcquireNotesReceivableNetOfProceedsFromCollection	0	usd
CY2021	cweb	Payments To Acquire Notes Receivable Net Of Proceeds From Collection PaymentsToAcquireNotesReceivableNetOfProceedsFromCollection	510000	usd
CY2022	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	0	usd
CY2021	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	8000000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-606000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	395000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11789000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-64000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8257000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	52761000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-308000	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-248000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	52389000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8039000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	47469000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-33309000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52803000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66963000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	31399000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	3060000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2500000	usd
CY2022	cweb	Reduction To Cultivation Liabilities For Inventory Provision ReductionToCultivationLiabilitiesForInventoryProvision	0	usd
CY2021	cweb	Reduction To Cultivation Liabilities For Inventory Provision ReductionToCultivationLiabilitiesForInventoryProvision	-543000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make informed estimates, judgments and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, the reported amounts of revenues and expenses during the reporting period and the disclosures in the accompanying notes. On an ongoing basis, management evaluates such estimates and assumptions for continued reasonableness. In particular, management makes estimates with respect to any (i) inventory provision, (ii) underlying assumptions that affect the potential impairment of goodwill and long-lived assets, (iii) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ability to realize income tax benefits associated with deferred tax assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and, (iv) underlying assumptions that affect the fair value of the SBH purchase option and other derivative instruments. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. Management’s estimates are based on historical information available at the date of the consolidated financial statements and various other assumptions management believes are reasonable based on the circumstances. Actual results could differ materially from those estimates.</span></div>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications and prior period presentations</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts presented in prior periods have been reclassified to conform with the current period presentation.</span></div>
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial instruments that are potentially exposed to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The cash amounts in deposit accounts held in excess of federally-insured limits were $66,713 and $19,244 as of December 31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides credit to its customers in the normal course of business and has established credit evaluation and monitoring processes to mitigate credit risk, but has limited risk, as the majority of its sales are transacted with cash.</span></div>
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	66713000	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	19244000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2612000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6224000	usd
CY2022Q4	cweb	Media Rights Current MediaRightsCurrent	2500000	usd
CY2021Q4	cweb	Media Rights Current MediaRightsCurrent	0	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2313000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	925000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	573000	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1441000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7998000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8590000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74139000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96092000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	23394000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	9729000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	12211000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	17523000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3435000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5502000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	540000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	441000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	221000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	179000	usd
CY2022Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	2300000	usd
CY2022Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	2300000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1320000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3620000	usd
CY2022Q4	cweb	Derivative And Other Liabilities Noncurrent DerivativeAndOtherLiabilitiesNoncurrent	12995000	usd
CY2021Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	13000000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2021Q1	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	8000000	usd
CY2021Q1	cweb	Business Combination Purchase Option Term BusinessCombinationPurchaseOptionTerm	P5Y
CY2021Q1	cweb	Business Combination Purchase Option Extension Term BusinessCombinationPurchaseOptionExtensionTerm	P2Y
CY2021Q1	cweb	C Class Of Warrant Or Right Percentage Of Outstanding Shares CClassOfWarrantOrRightPercentageOfOutstandingShares	0.10
CY2021Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P60D
CY2022	cweb	Gain Loss On Fair Value Adjustment Business Combination Purchase Option GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption	-10700000	usd
CY2021	cweb	Gain Loss On Fair Value Adjustment Business Combination Purchase Option GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption	5000000	usd
CY2022Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	2300000	usd
CY2021Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	13000000	usd
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	10000000	shares
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4304000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	34763000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	38249000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10960000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	15189000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13237000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13974000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	58960000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	67412000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	32007000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	15335000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	26953000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	52077000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	23394000	usd
CY2022Q4	us-gaap	Inventory Write Down InventoryWriteDown	20349000	usd
CY2022	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	6722000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	9729000	usd
CY2021	cweb	Inventory Provisions Settlement Reduction Of Cultivation Liabilities InventoryProvisionsSettlementReductionOfCultivationLiabilities	543000	usd
CY2021	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	12129000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	48162000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	47321000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19003000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13829000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29330000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36085000	usd
CY2022	us-gaap	Depreciation Depreciation	6213000	usd
CY2021	us-gaap	Depreciation Depreciation	7481000	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1921000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	76039000	usd
CY2022	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P18Y11M4D
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3514000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1621000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	150000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	150000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3664000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1893000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1771000	usd
CY2021	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P20Y14D
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5059000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2366000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2693000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	150000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	150000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5209000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2366000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2843000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	19750000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1228000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3544000	usd
CY2022Q4	cweb	Licensed Properties LicensedProperties	23399000	usd
CY2022Q4	cweb	Media Rights MediaRights	7482000	usd
CY2022Q4	cweb	Media Rights Current MediaRightsCurrent	2500000	usd
CY2022Q4	cweb	Media Rights Noncurrent MediaRightsNoncurrent	4982000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3205000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2896000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2172000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1847000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	13698000	usd
CY2022Q4	cweb	License Payable Current LicensePayableCurrent	7759000	usd
CY2022Q4	cweb	License Payable Noncurrent LicensePayableNoncurrent	20383000	usd
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	10000000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2074000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	2969000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1572000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	1512000	usd
CY2022	cweb	Lease Cost Excluding Sublease Income LeaseCostExcludingSubleaseIncome	3646000	usd
CY2021	cweb	Lease Cost Excluding Sublease Income LeaseCostExcludingSubleaseIncome	4481000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	940000	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	724000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	3471000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	3528000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2350000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3368000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	27186000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6975000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	20211000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2306000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17905000	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1837000	usd
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2022	cweb	Cultivation Settlement Reduction CultivationSettlementReduction	582000	usd
CY2021	cweb	Cultivation Settlement Reduction CultivationSettlementReduction	855000	usd
CY2020Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	9304000	usd
CY2020Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	2513000	usd
CY2020Q4	cweb	Cultivation Liabilities CultivationLiabilities	11817000	usd
CY2021	cweb	Cultivation Liability Settlement Payments Current CultivationLiabilitySettlementPaymentsCurrent	7166000	usd
CY2021	cweb	Cultivation Liability Settlement Payments Noncurrent CultivationLiabilitySettlementPaymentsNoncurrent	0	usd
CY2021	cweb	Cultivation Liability Settlement Payments CultivationLiabilitySettlementPayments	7166000	usd
CY2021	cweb	Cultivation Liability Settlement Reduction Current CultivationLiabilitySettlementReductionCurrent	855000	usd
CY2021	cweb	Cultivation Liability Settlement Reduction Noncurrent CultivationLiabilitySettlementReductionNoncurrent	0	usd
CY2021	cweb	Cultivation Liability Settlement Reduction CultivationLiabilitySettlementReduction	855000	usd
CY2021	cweb	Cultivation Liability Interest Expense Current CultivationLiabilityInterestExpenseCurrent	37000	usd
CY2021	cweb	Cultivation Liability Interest Expense Noncurrent CultivationLiabilityInterestExpenseNoncurrent	0	usd
CY2021	cweb	Cultivation Liability Interest Expense CultivationLiabilityInterestExpense	37000	usd
CY2021	cweb	Cultivation Liability Conversion To Short Term Borrowing Current CultivationLiabilityConversionToShortTermBorrowingCurrent	2128000	usd
CY2021	cweb	Cultivation Liability Conversion To Short Term Borrowing Noncurrent CultivationLiabilityConversionToShortTermBorrowingNoncurrent	-2128000	usd
CY2021	cweb	Cultivation Liability Conversion To Short Term Borrowing CultivationLiabilityConversionToShortTermBorrowing	0	usd
CY2021Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	3448000	usd
CY2021Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	385000	usd
CY2021Q4	cweb	Cultivation Liabilities CultivationLiabilities	3833000	usd
CY2022	cweb	Cultivation Liability Settlement Payments Current CultivationLiabilitySettlementPaymentsCurrent	3049000	usd
CY2022	cweb	Cultivation Liability Settlement Payments Noncurrent CultivationLiabilitySettlementPaymentsNoncurrent		usd
CY2022	cweb	Cultivation Liability Settlement Payments CultivationLiabilitySettlementPayments	3049000	usd
CY2022	cweb	Cultivation Liability Settlement Reduction Current CultivationLiabilitySettlementReductionCurrent	582000	usd
CY2022	cweb	Cultivation Liability Settlement Reduction Noncurrent CultivationLiabilitySettlementReductionNoncurrent		usd
CY2022	cweb	Cultivation Liability Settlement Reduction CultivationLiabilitySettlementReduction	582000	usd
CY2022	cweb	Cultivation Liability Costs Incurred Current CultivationLiabilityCostsIncurredCurrent	206000	usd
CY2022	cweb	Cultivation Liability Costs Incurred Noncurrent CultivationLiabilityCostsIncurredNoncurrent	6000	usd
CY2022	cweb	Cultivation Liability Costs Incurred CultivationLiabilityCostsIncurred	212000	usd
CY2022	cweb	Cultivation Liability Interest Expense Current CultivationLiabilityInterestExpenseCurrent	37000	usd
CY2022	cweb	Cultivation Liability Interest Expense Noncurrent CultivationLiabilityInterestExpenseNoncurrent		usd
CY2022	cweb	Cultivation Liability Interest Expense CultivationLiabilityInterestExpense	37000	usd
CY2022	cweb	Cultivation Liability Conversion To Short Term Borrowing Current CultivationLiabilityConversionToShortTermBorrowingCurrent	385000	usd
CY2022	cweb	Cultivation Liability Conversion To Short Term Borrowing Noncurrent CultivationLiabilityConversionToShortTermBorrowingNoncurrent	-385000	usd
CY2022	cweb	Cultivation Liability Conversion To Short Term Borrowing CultivationLiabilityConversionToShortTermBorrowing	0	usd
CY2022Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	445000	usd
CY2022Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	6000	usd
CY2022Q4	cweb	Cultivation Liabilities CultivationLiabilities	451000	usd
CY2022Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	450000	usd
CY2022Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	6000	usd
CY2022Q4	us-gaap	Contractual Obligation ContractualObligation	456000	usd
CY2022Q4	cweb	Contractual Obligation Undiscounted Excess Amount ContractualObligationUndiscountedExcessAmount	5000	usd
CY2022Q4	cweb	Cultivation Liabilities CultivationLiabilities	451000	usd
CY2022Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	445000	usd
CY2022Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	6000	usd
CY2022Q4	cweb	Common Stock Voting Rights Number Of Votes CommonStockVotingRightsNumberOfVotes	1	vote
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	142335464	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	142335464	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Issued ProportionateVotingStockSharesIssued	0	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Outstanding ProportionateVotingStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Outstanding ProportionateVotingStockSharesOutstanding	0	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Issued ProportionateVotingStockSharesIssued	0	shares
CY2022Q4	cweb	Proportionate Voting Stock Shares Outstanding ProportionateVotingStockSharesOutstanding	0	shares
CY2022Q4	cweb	Proportionate Voting Stock Shares Issued ProportionateVotingStockSharesIssued	0	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2022Q2	cweb	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	1233140	shares
CY2022Q2	cweb	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	15.29
CY2022Q2	cweb	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	5750000	shares
CY2022Q2	cweb	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	6.27
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6983140	shares
CY2021Q4	cweb	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	7.86
CY2022	cweb	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0	shares
CY2022	cweb	Class Of Warrant Or Right Exercised Weighted Average Exercise Price ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice	0
CY2022	cweb	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	6983140	shares
CY2022	cweb	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	7.86
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2022Q4	cweb	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	0
CY2021Q2	cweb	Sale Of Stock Maximum Value Of Shares Offered SaleOfStockMaximumValueOfSharesOffered	60000000	cad
CY2021	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4740300	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.85
CY2021	cweb	Sale Of Stock Gross Consideration Received On Transaction SaleOfStockGrossConsiderationReceivedOnTransaction	8714000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	596000	usd
CY2021	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	8118000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	64000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59313000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-137722000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146631767	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	140769247	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146631767	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140769247	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.98
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35114431	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12143874	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	13500000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	8009248	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.830
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.860
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.820
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.865
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.018
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.033
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.013
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.017
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3343883	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.16
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M14D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1039000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3813579	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.11
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3200435	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.75
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3957027	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.52
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M13D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	47000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1669287	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.55
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M14D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M13D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.11
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M14D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.56
CY2022	cweb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice	0
CY2021	cweb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice	4.85
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	458102	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.60
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	720261	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	5.93
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3957027	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1462000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	751000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1816851	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.28
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3823267	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.87
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1797430	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.04
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1273114	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.54
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2569574	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.98
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3567000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5483000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3239000	usd
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4638000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-59153000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-137589000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-69000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	10000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-59222000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-137579000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-50000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	87000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	33000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	4000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	160000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	91000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	143000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	91000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	143000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.033
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.018
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.020
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.003
CY2022	cweb	Effective Income Tax Rate Reconciliation Nondeductible Expense Change In Fair Value Of Financial Instruments And Other Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfFinancialInstrumentsAndOtherPercent	-0.027
CY2021	cweb	Effective Income Tax Rate Reconciliation Nondeductible Expense Change In Fair Value Of Financial Instruments And Other Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfFinancialInstrumentsAndOtherPercent	0.014
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.114
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.248
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.125
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.007
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.004
CY2022	cweb	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	0.052
CY2021	cweb	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.008
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.005
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	10764000	usd
CY2022	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	10841000	usd
CY2022Q4	cweb	Deferred Tax Assets Operating Loss And Other Loss Carryforwards DeferredTaxAssetsOperatingLossAndOtherLossCarryforwards	53997000	usd
CY2021Q4	cweb	Deferred Tax Assets Operating Loss And Other Loss Carryforwards DeferredTaxAssetsOperatingLossAndOtherLossCarryforwards	45557000	usd
CY2022Q4	cweb	Deferred Tax Assets Inventory And Unicap263 A DeferredTaxAssetsInventoryAndUNICAP263A	8079000	usd
CY2021Q4	cweb	Deferred Tax Assets Inventory And Unicap263 A DeferredTaxAssetsInventoryAndUNICAP263A	4191000	usd
CY2022Q4	cweb	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	4972000	usd
CY2021Q4	cweb	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	5586000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1733000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	976000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1853000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2061000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1020000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	71818000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	58207000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	67582000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	52888000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4236000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5319000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	4063000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	5110000	usd
CY2022Q4	cweb	Deferred Tax Liabilities Warrants DeferredTaxLiabilitiesWarrants	173000	usd
CY2021Q4	cweb	Deferred Tax Liabilities Warrants DeferredTaxLiabilitiesWarrants	209000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4236000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5319000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	14694000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	17203000	usd
CY2022Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	2205000	usd
CY2021Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1788000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	179000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	40000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	221000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	134000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	52000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	7000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	179000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	4106000	usd
CY2020Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	1000000	usd
CY2020Q4	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.0325
CY2022Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	1037000	usd
CY2022Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	1037000	usd
CY2021Q1	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	8000000	usd

Files In Submission

Name	View Source	Status
0001750155-23-000021-index-headers.html	Edgar Link	pending
0001750155-23-000021-index.html	Edgar Link	pending
0001750155-23-000021.txt	Edgar Link	pending
0001750155-23-000021-xbrl.zip	Edgar Link	pending
cweb-20221231.htm	Edgar Link	pending
cweb-20221231.xsd	Edgar Link	pending
ex1025.htm	Edgar Link	pending
ex1030.htm	Edgar Link	pending
ex1031.htm	Edgar Link	pending
ex211.htm	Edgar Link	pending
ex231.htm	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
ex322.htm	Edgar Link	pending
ex43.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
cweb-20221231_cal.xml	Edgar Link	unprocessable
cweb-20221231_lab.xml	Edgar Link	unprocessable
cweb-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cweb-20221231_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cweb-20221231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBHF
Stock $cwbhf

2023 Q1 Form 10-K Financial Statement

#000175015523000021 Filed on March 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBHF Stock $cwbhf

2023 Q1 Form 10-K Financial Statement

#000175015523000021 Filed on March 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBHF
Stock $cwbhf